Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Plaque Psoriasis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00658788
What this trial is testing

Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis

Who this might be right for
Psoriasis
Galderma R&D 305
Not applicableStudy completedNCT03236870
What this trial is testing

Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China

Who this might be right for
Psoriasis
AbbVie 181
Testing effectiveness (Phase 2)Study completedNCT01096862
What this trial is testing

Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Astellas Pharma Inc 124
Testing effectiveness (Phase 2)Study completedNCT01855880
What this trial is testing

Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
AbGenomics B.V Taiwan Branch 54
Testing effectiveness (Phase 2)Study completedNCT01072383
What this trial is testing

Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis Vulgaris
Biotest 49
Large-scale testing (Phase 3)Study completedNCT03766685
What this trial is testing

Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis
UCB Biopharma SRL 172
Post-approval studies (Phase 4)Study completedNCT00249808
What this trial is testing

Efalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies

Who this might be right for
Psoriasis
Merck KGaA, Darmstadt, Germany 1,266
Early research (Phase 1)Study completedNCT03718884
What this trial is testing

Mirikizumab in Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 29
Large-scale testing (Phase 3)Study completedNCT03073200
What this trial is testing

Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 201
Large-scale testing (Phase 3)Study completedNCT03090100
What this trial is testing

Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 1,048
Testing effectiveness (Phase 2)Study completedNCT03392168
What this trial is testing

Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Arcutis Biotherapeutics, Inc. 91
Post-approval studies (Phase 4)WithdrawnNCT00832364
What this trial is testing

Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis

Who this might be right for
Plaque Psoriasis
Stiefel, a GSK Company
Early research (Phase 1)Study completedNCT06143371
What this trial is testing

Investigate the Safety and Tolerability of CAN10 Antibody in Healthy Subjects and in Subjects With Plaque Psoriasis.

Who this might be right for
HealthyPlaque Psoriasis
Otsuka Pharmaceutical Development & Commercialization, Inc. 80
Testing effectiveness (Phase 2)Temporarily pausedNCT06723171
What this trial is testing

Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis

Who this might be right for
PsoriasisPlaque Type PsorisisPlaque Psoriasis
Io Therapeutics 20
Large-scale testing (Phase 3)Study completedNCT03123471
What this trial is testing

The Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp

Who this might be right for
Psoriasis
Amgen 303
Testing effectiveness (Phase 2)Study completedNCT01018134
What this trial is testing

Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 151
Large-scale testing (Phase 3)Study completedNCT00195676
What this trial is testing

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 1,469
Large-scale testing (Phase 3)Looking for participantsNCT07362017
What this trial is testing

Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate-to-severe Chronic Plaque Psoriasis
Vanda Pharmaceuticals 300
Large-scale testing (Phase 3)UnknownNCT03927352
What this trial is testing

The Purpose of This Research Study is to Compare the Efficacy and Safety of SCT630 and Adalimumab (HUMIRA®) in Adults With Plaque Psoriasis

Who this might be right for
Psoriasis
Sinocelltech Ltd. 330
Early research (Phase 1)Study completedNCT04316585
What this trial is testing

Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants

Who this might be right for
Psoriasis
GlaxoSmithKline 29
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation